Monoclonal antibodies for prophylaxis and therapy of respiratory syncytial virus, SARS-CoV-2, human immunodeficiency virus, rabies and bacterial infections: an update from the World Association of Infectious Diseases and Immunological Disorders and the Italian Society of Antinfective Therapy

Susanna Esposito, Nicola Principi, Gayatri Amirthalingam et al.|Frontiers in Immunology|2023

Cited by 28